| 1 |
30522045 | Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer. | 2019 Feb |
1 |
| 2 |
27807662 | C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells. | 2017 Feb |
1 |
| 3 |
26097873 | Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells. | 2015 |
1 |
| 4 |
26516583 | FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity. | 2015 Oct |
1 |
| 5 |
24366851 | Quercetin and sorafenib as a novel and effective couple in programmed cell death induction in human gliomas. | 2014 Jul |
1 |
| 6 |
23108376 | OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma. | 2013 Jan |
1 |
| 7 |
23384035 | Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization. | 2013 Apr |
1 |
| 8 |
21604268 | Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli. | 2012 Apr |
1 |
| 9 |
20054642 | Synergistic activity of letrozole and sorafenib on breast cancer cells. | 2010 Nov |
1 |
| 10 |
20197401 | Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. | 2010 Mar |
1 |
| 11 |
20473320 | The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cells. | 2010 Jul |
1 |
| 12 |
17634558 | Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation. | 2007 Jul 15 |
1 |
| 13 |
17909059 | The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. | 2007 Oct 1 |
1 |
| 14 |
16452220 | The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cells. | 2006 Feb 1 |
1 |
| 15 |
16985072 | Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. | 2006 Sep |
1 |
| 16 |
16109713 | Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. | 2005 Oct 21 |
3 |